Resource Guide: FDA warning Avelumab Merkel cell carcinoma

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Featured analysis

FDA warning Avelumab Merkel cell carcinoma: A Detailed Overview — detailed background and analysis.


National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.